{
  "meta": {
    "timestamp": "2025-01-06T10:56:20.672255",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Cytek Biosciences Inc",
      "symbol": "CTKB",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Market Competition: Intense competition in the flow cytometry market could pressure margins and market share.",
            "Regulatory Challenges: Compliance with evolving regulations in new geographic markets or clinical applications poses significant risk.",
            "Supply Chain Vulnerabilities: Reliance on a global supply chain exposes the company to potential disruptions.",
            "Macroeconomic Environment: Challenging macroeconomic conditions could continue to affect growth and profitability."
          ],
          "controversies": [
            "Media Sentiment: Cytek's media sentiment score of 1.35 lags behind some competitors, indicating less favorable media coverage.",
            "Short Interest: Decrease in short interest by 6.6% suggests a potential shift in market sentiment towards the stock."
          ],
          "environmental_issues": [],
          "social_issues": [],
          "governance_issues": [],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "2023 Annual Report - Cytek Biosciences",
              "snippet": "Dear Cytek Stockholders: Cytek Biosciences achieved another consecutive year of growth in 2023 with total revenue at ... tools industry - including Cytek - faced a challenging macro-economic environment in 2023. Our response to these challenges, together with our robust corporate strategy and ... and a new instrument, the Cytek Orion ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.470872+00:00",
              "published_date": null,
              "source_hash": "4c6f302f8bde6b2abdacc82ae7fc653c"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. - AnnualReports.com",
              "snippet": "Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) technology.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.470959+00:00",
              "published_date": null,
              "source_hash": "486a4512ba313f0a73c445d636ad492e"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. Approves $50 Million Stock Repurchase ... - Nasdaq",
              "snippet": "Cytek Biosciences, Inc. has announced a new stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $50 million of its common stock starting January 1 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.470981+00:00",
              "published_date": null,
              "source_hash": "6785c9132f6ede426b3bd01436cc1207"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. SEC 10-Q Report \u2014 TradingView News",
              "snippet": "Cytek Biosciences, Inc., a leading company in the field of cell analysis, has released its Form 10-Q report for the third quarter of 2024. The report highlights the company's financial performance, operational achievements, strategic initiatives, and the challenges it faces in the competitive marke\u2026",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.470996+00:00",
              "published_date": null,
              "source_hash": "614360d484e54a8e70cbe4b326414854"
            },
            {
              "url": "",
              "title": "Cytek\u00ae Biosciences Achieves ISO 13485 Certification at Headquarters",
              "snippet": "Certification Validates Company's Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United StatesFREMONT, Calif., Sept. 27, 2023 (GLOBE ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471013+00:00",
              "published_date": null,
              "source_hash": "36151521e4c9020cd6ce5744a4dc9d2f"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Reports Third Quarter 2024 Financial Results",
              "snippet": "About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471028+00:00",
              "published_date": null,
              "source_hash": "ea68e8ffc41b7fb1646029962c4c158d"
            },
            {
              "url": "",
              "title": "Cytek\u00ae Biosciences Achieves ISO 13485 Certification at Headquarters",
              "snippet": "Certification Validates Company's Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States FREMONT, Calif., September 27, 2023 - Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has received EN ISO 13485:2016 Quality Management System (QMS) certification. The ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471040+00:00",
              "published_date": null,
              "source_hash": "7ea94d1a2e8f2510e8d9db298b4772e0"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Announces $50 Million Stock ... - Markets Insider",
              "snippet": "About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471055+00:00",
              "published_date": null,
              "source_hash": "788dec11d12baf023df881182c32742f"
            },
            {
              "url": "",
              "title": "Company Cytek Biosciences, Inc. - MarketScreener.com",
              "snippet": "Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471067+00:00",
              "published_date": null,
              "source_hash": "84d436021314d017676d1cb4154a62f1"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Inc - Company Profile and News - Bloomberg Markets",
              "snippet": "Cytek Biosciences, Inc. operates as a cell analysis solutions company. The Company offers solutions that enable scientists to obtain deep biological insights through high parametric datasets and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:54.471079+00:00",
              "published_date": null,
              "source_hash": "0f2898f7db2f9646ed9dd413eebb2e02"
            },
            {
              "url": "",
              "title": "Cytek Biosciences",
              "snippet": "Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:05.289578+00:00",
              "published_date": "2024-12-31T00:00:00+00:00",
              "source_hash": "e5578ad9bc7e9e347042e942dfbc119f"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025",
              "snippet": "Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a stock repurchase program for up to an additional aggregate of $50 million of its common stock,",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:05.289722+00:00",
              "published_date": "2024-12-30T13:19:00+00:00",
              "source_hash": "cf3af728103394b25725ab484a256da3"
            },
            {
              "url": "",
              "title": "Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference",
              "snippet": "FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:05.289698+00:00",
              "published_date": "2025-01-02T14:00:00+00:00",
              "source_hash": "be5f90fb122521c9155af295190ab237"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. (CTKB)",
              "snippet": "The new repurchase program is authorized to commence on January 1, 2025 an FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:57.133576+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "4a9808aaa704045b12e6668aeec5ae01"
            },
            {
              "url": "",
              "title": "Cytek\u00ae Biosciences Named \"Overall BioTech Company of the Year\" in 2024 BioTech Breakthrough Awards Program",
              "snippet": "Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB ... regarding the use of Cytek products to solve critical challenges. Cytek also offers a robust array of educational ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc regulatory challenges in new markets",
              "retrieved_at": "2025-01-06T17:55:57.133598+00:00",
              "published_date": "2024-11-19T22:00:00+00:00",
              "source_hash": "808923eb7c1b10c753a7eaba966d93aa"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. Updated August 2024: Supply Chain Analysis | Ark.ai",
              "snippet": "Cytek Biosciences, Inc. has 14 subsidiaries and 28 Tier 1 supply chain connections. Their prime government contract revenue over the past three years is $13.11M. Information about Cytek Biosciences, Inc.'s federal profile including a list of suppliers, list of primes, and list of customers are included in the following tables.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668752+00:00",
              "published_date": null,
              "source_hash": "23193a0fa6a31118abe1ad9da5be3ab3"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. SEC 10-Q Report \u2014 TradingView News",
              "snippet": "Cytek Biosciences, Inc., a leading company in the field of cell analysis, has released its Form 10-Q report for the third quarter of 2024. ... Any disruption in the supply chain could adversely affect the company's business, financial condition, and results of operations. ... Business Disruptions: The company's operations could be subject ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668852+00:00",
              "published_date": null,
              "source_hash": "1e9ffa54a6469549a647d7601404b56e"
            },
            {
              "url": "",
              "title": "Supply Chain Data Of Cytek Biosciences Inc Company Profile - Trademo",
              "snippet": "Find shipment details and trends, top products imported and exported, buyers, suppliers, contact details of Cytek Biosciences Inc, and much more with Trademo. We have launched multi tier supply chain mapping tool for compliance teams to check and mitigate risks in extended supply chains. Explore Now. Request a Demo. Product.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668872+00:00",
              "published_date": null,
              "source_hash": "b5178a64f1a59684decb9ac6b842fb25"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Reports Third Quarter 2024 Financial Results",
              "snippet": "FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (\"Cytek Biosciences\" or \"Cytek\") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668884+00:00",
              "published_date": null,
              "source_hash": "a36964c8e3faa8d2a12491baf4e8ce29"
            },
            {
              "url": "",
              "title": "Supply and License Agreement, by and between Biotium, Inc. and | Cytek ...",
              "snippet": "Supply and License Agreement, by and between Biotium, Inc. and Cytek Biosciences, Inc., dated as of September 1, 2020 Contract Categories: Intellectual Property - License Agreements EX-10.11 8 d80783dex1011.htm EX-10.11 EX-10.11",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668894+00:00",
              "published_date": null,
              "source_hash": "412c852e202f8355068cad3bbf199b70"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue ...",
              "snippet": "Cytek Biosciences Inc (CTKB) reports a 7% revenue growth and a positive net income, while navigating softer US market conditions and maintaining strong global demand.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668908+00:00",
              "published_date": null,
              "source_hash": "249d7cee4a1fc3a00028d986c3686f9d"
            },
            {
              "url": "",
              "title": "Q3 2024 Cytek Biosciences Inc Earnings Call - Yahoo Finance",
              "snippet": "Paul Goodson. Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended September 30th, 2024. If you have not received this news release or if you'd ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668918+00:00",
              "published_date": null,
              "source_hash": "f6e99b4f67df863f67950772048e5805"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Company Profile | Management and Employees ... - Datanyze",
              "snippet": "Cytek Biosciences Profile and History. Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) technology.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668928+00:00",
              "published_date": null,
              "source_hash": "4cb628eab319318b3fd2ec2d4673fbe5"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Information - RocketReach",
              "snippet": "Cytek\u00ae Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek's compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. ... Senior Vice President Global Operations and Integrated Supply Chain at Cytek Biosciences Pleasanton ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:55:58.668939+00:00",
              "published_date": null,
              "source_hash": "db58d1e217f8baabf208904b4d5b91c0"
            },
            {
              "url": "",
              "title": "Cytek Biosciences - Overview, News & Similar companies - ZoomInfo",
              "snippet": "Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024 FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8th, 2024.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869061+00:00",
              "published_date": null,
              "source_hash": "337fdbedfcc54b1e4956c5522fc99cf2"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Inc (CTKB)",
              "snippet": "View the CTKB option chain and compare options of Cytek Biosciences Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:56:01.328192+00:00",
              "published_date": "2022-09-20T22:53:00+00:00",
              "source_hash": "9cb5721768ae6b8cd45878739df679b1"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday",
              "snippet": "Cytek Biosciences announced a $50 million stock buyback program for 2025. Cytek Biosciences shares jumped 6.1% to $6.78 on Monday. Here are some other big stocks recording gains in today's session.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:56:01.328222+00:00",
              "published_date": "2024-12-30T14:23:00+00:00",
              "source_hash": "617199db4ad9e712b962a44bc63bd4df"
            },
            {
              "url": "",
              "title": "Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference",
              "snippet": "FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:56:01.328249+00:00",
              "published_date": "2025-01-02T13:06:00+00:00",
              "source_hash": "a8b876766d5daf529e956c1fc8830afa"
            },
            {
              "url": "",
              "title": "Cytek Biosciences, Inc. (CTKB) Surges 10.3%: Is This an Indication of Further Gains?",
              "snippet": "Cytek Biosciences, Inc. (CTKB) shares ended the last trading session 10.3% higher at $8.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T17:56:01.328273+00:00",
              "published_date": "2024-01-09T13:54:00+00:00",
              "source_hash": "4b54db985b385ac0542adbdc4ccc67af"
            },
            {
              "url": "",
              "title": "Cytek Biosciences (CTKB) Competitors and Alternatives 2025 - MarketBeat",
              "snippet": "In the previous week, Cytek Biosciences had 11 more articles in the media than Transcat. MarketBeat recorded 13 mentions for Cytek Biosciences and 2 mentions for Transcat. Transcat's average media sentiment score of 1.61 beat Cytek Biosciences' score of 1.35 indicating that Transcat is being referred to more favorably in the media.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.868881+00:00",
              "published_date": null,
              "source_hash": "2bd025f45865b72474e25d32757e4203"
            },
            {
              "url": "",
              "title": "Cytek BioSciences Inc: Business Model, SWOT Analysis, and Competitors ...",
              "snippet": "Regulatory Challenges: The biotechnology industry is heavily regulated, and compliance with changing regulations can pose challenges for product development and market entry. Competitors. Cytek BioSciences faces competition from several key players in the biotechnology and flow cytometry market. Below are some of its primary competitors in 2024: 1.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.868986+00:00",
              "published_date": null,
              "source_hash": "c86f5a657b836ee0f5a0f047ee26f486"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Inc Comparisons to its Competitors and Market Share ...",
              "snippet": "Cytek Biosciences Inc 's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - CSIMarket",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869001+00:00",
              "published_date": null,
              "source_hash": "b20c7fa607bc129ae74f01dd0a6c14be"
            },
            {
              "url": "",
              "title": "Top Cytek Biosciences Competitors and Alternatives | Craft.co",
              "snippet": "Cytek Biosciences's main competitors include Thermo Fisher Scientific, Miltenyi Biotec, Standard BioTools, BD and Beckman Coulter. Compare Cytek Biosciences to its competitors by revenue, employee growth and other metrics at Craft.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869012+00:00",
              "published_date": null,
              "source_hash": "8d9cf11f74b17537a947355604cbe7b1"
            },
            {
              "url": "",
              "title": "Cytek Company Profile 2024: Stock Performance & Earnings - PitchBook",
              "snippet": "Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by lever ... What is the current market cap of Cytek? The current market capitalization of Cytek is $814M. ... FluoroFinder, Active Motif, and Treefrog Therapeutics are competitors of Cytek. What is Cytek's annual earnings per share ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869024+00:00",
              "published_date": null,
              "source_hash": "9c21534b26180f61efc15cb06b6be169"
            },
            {
              "url": "",
              "title": "Cytek Biosciences - Products, Competitors, Financials, Employees ...",
              "snippet": "Cytek Biosciences, Inc. has a fifty-two week low of $3.80 and a fifty-two week high of $9.87. The firm has a market capitalization of $973.17 million, a price-to-earnings ratio of -50.50 and a beta of 1.32. ... equities analysts forecast that Cytek Biosciences, Inc. will post -0.14 earnings per share for the current year. Cytek Biosciences ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869033+00:00",
              "published_date": null,
              "source_hash": "790ee5292d7dd51b313a34ab40c1f328"
            },
            {
              "url": "",
              "title": "Cytek Biosciences (CTKB) Stock Price, News & Analysis - MarketBeat",
              "snippet": "Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. ... Price to Book Value per Share Ratio. Cytek Biosciences has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869043+00:00",
              "published_date": null,
              "source_hash": "ca3f874aae059395f2e6d783d0fcff81"
            },
            {
              "url": "",
              "title": "Checking In On Cytek Biosciences Stock (NASDAQ:CTKB)",
              "snippet": "Cytek was founded as Cytoville in 2014 and went public in July 2021, raising net proceeds of $215.7 million at $17 per share. Its stock trades just over $11.00 a share, translating to a market cap ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869052+00:00",
              "published_date": null,
              "source_hash": "35b4e0f5c319a25c9a674733d52c5235"
            },
            {
              "url": "",
              "title": "Cytek Biosciences Inc, 8EQ:BER summary - FT.com - Financial Times",
              "snippet": "Latest Cytek Biosciences Inc (8EQ:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Cytek Biosciences Inc, 8EQ:BER summary - FT.com",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:02.869070+00:00",
              "published_date": null,
              "source_hash": "83afe621bb211e1b531134b0b2060027"
            },
            {
              "url": "",
              "title": "Short Interest in Cytek Biosciences, Inc. (NASDAQ:CTKB) Decreases By 6.6%",
              "snippet": "Cytek Biosciences stock opened at $6.49 on Thursday. The company has a 50 day moving average price of $6.24 and a 200 day moving average price of $5.80. Cytek Biosciences has a 52 week low of $4.66 and a 52 week high of $9.33. The firm has a market ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:05.289667+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "c939fd3cead935d0899002a724de0074"
            },
            {
              "url": "",
              "title": "Cytek Biosciences (NASDAQ:CTKB) Shares Up 5.9% - Here's What Happened",
              "snippet": "Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) shares traded up 5.9% during mid-day trading on Monday . The company traded as high as $6.83 and last traded at $6.77. 97,485 shares changed hands during mid-day trading,",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Cytek Biosciences Inc Cytek Biosciences Inc competition and market share controversies",
              "retrieved_at": "2025-01-06T17:56:05.289744+00:00",
              "published_date": "2024-12-30T16:49:00+00:00",
              "source_hash": "1c31529e212bc011ff66eb222d130448"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Cytek Biosciences Inc regulatory challenges in new markets",
              "rationale": "Investigate potential legal and regulatory hurdles in expanding geographic markets",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Cytek Biosciences Inc supply chain disruptions",
              "rationale": "Assess risks related to global supply chain dependencies and potential impacts on operations",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Cytek Biosciences Inc competition and market share controversies",
              "rationale": "Explore competitive pressures and any controversies related to market positioning",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T10:56:20.672263",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}